Klug-entscheiden-Empfehlungen in der Kardiologie

This article describes controversially discussed Choosing wisely recommendations presented by the German Cardiac Society: anticoagulation therapy in patients with atrial fibrillation and “only” moderate stroke risk, on the one hand, and goal-directed low-density lipoprotein (LDL) cholesterol-lowerin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Werdan, Karl (VerfasserIn) , Katus, Hugo (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Deutsch
Veröffentlicht: June 2017
In: Der Internist
Year: 2017, Jahrgang: 58, Heft: 6, Pages: 556-567
ISSN:1432-1289
DOI:10.1007/s00108-017-0239-7
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00108-017-0239-7
Verlag, Volltext: https://doi.org/10.1007/s00108-017-0239-7
Volltext
Verfasserangaben:K. Werdan, S. Baldus, N. Frey, U. Nixdorff, K.-H. Kuck, H. Katus
Beschreibung
Zusammenfassung:This article describes controversially discussed Choosing wisely recommendations presented by the German Cardiac Society: anticoagulation therapy in patients with atrial fibrillation and “only” moderate stroke risk, on the one hand, and goal-directed low-density lipoprotein (LDL) cholesterol-lowering, on the other. Presuming an adequate regime, patients with atrial fibrillation and only moderate risk of stroke (CHA2DS2-VASc Score of 1 in men and of 2 in women) also benefit from anticoagulation therapy, even in elderly patients. In patients with coronary heart disease, the German Cardiac Society recommends reducing LDL-cholesterol serum levels with a statin to values lower than 70 mg/dl (1.8 mmol/l) or at least reducing the basal level by 50%. With this recommendation, the German Cardiac Society unequivocally prioritizes the “goal-oriented statin therapy” above the “statin strategy of fixed dose”. The reasons for this preference are discussed.
Beschreibung:Gesehen am 26.11.2018
Beschreibung:Online Resource
ISSN:1432-1289
DOI:10.1007/s00108-017-0239-7